To determine whether loss of p16 reduces HCC cell migration, we infected the BL185 HCC cell line with viral vectors encoding shRNAs against mouse p16 or p19 and specific knockdown confirmed by immunoblot (Figure 1C). Here, CDKN2A is linked to hepatocellular carcinoma.